Splenic marginal zone lymphoma: A prognostic model for clinical use

206Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

Abstract

The Integruppo Italiano Linfomi (IIL) carried out a study to assess the outcomes of splenic marginal zone lymphoma and to identify prognostic factors in 309 patients. The 5-year cause-specific survival (CSS) rate was 76%. In univariate analysis, the parameters predictive of shorter CSS were hemoglobin levels below 12 g/dL (P < .001), lactate dehydrogenase (LDH) levels above normal (P

Cite

CITATION STYLE

APA

Arcaini, L., Lazzarino, M., Colombo, N., Burcheri, S., Boveri, E., Paulli, M., … Iannitto, E. (2006). Splenic marginal zone lymphoma: A prognostic model for clinical use. Blood, 107(12), 4643–4649. https://doi.org/10.1182/blood-2005-11-4659

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free